Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A neutrophil response linked to tumor control in immunotherapy
Jeremy Gungabeesoon, Nicolas A. Gort-Freitas, Máté Kiss, et al.
Cell (2023) Vol. 186, Iss. 7, pp. 1448-1464.e20
Closed Access | Times Cited: 199

Showing 1-25 of 199 citing articles:

Precision treatment in advanced hepatocellular carcinoma
Xupeng Yang, Chen Yang, Shu Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 180-197
Open Access | Times Cited: 112
Neutrophil profiling illuminates anti-tumor antigen-presenting potency
Yingcheng Wu, Jiaqiang Ma, Xupeng Yang, et al.
Cell (2024) Vol. 187, Iss. 6, pp. 1422-1439.e24
Closed Access | Times Cited: 94
Dendritic cells as shepherds of T cell immunity in cancer
Mikaël J. Pittet, Mauro Di Pilato, Christopher Garris, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2218-2230
Open Access | Times Cited: 88
CD300ld on neutrophils is required for tumour-driven immune suppression
Chaoxiong Wang, Xichen Zheng, Jinlan Zhang, et al.
Nature (2023) Vol. 621, Iss. 7980, pp. 830-839
Closed Access | Times Cited: 62
Interferon-stimulated neutrophils as a predictor of immunotherapy response
Madeleine Benguigui, Tim J. Cooper, Prajakta Kalkar, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 253-265.e12
Open Access | Times Cited: 53
Neutrophil diversity in inflammation and cancer
Silvia Carnevale, Irene Di Ceglie, Giovanna Grieco, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 46
Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy
Marit J. van Elsas, Jim Middelburg, Camilla Labrie, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 1032-1050.e10
Open Access | Times Cited: 38
Roles of exosomes in immunotherapy for solid cancers
C. Lyu, Haifeng Sun, Zhenqiang Sun, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 36
Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment
Xiujuan Han, Chunai Gong, Qingru Yang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 571-608
Open Access | Times Cited: 35
Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives
Ke-Yu Shen, Ying Zhu, Sun‐Zhe Xie, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 35
Neutrophils in Cancer immunotherapy: friends or foes?
Xueqin Huang, Eugenie Nepovimová, Vojtěch Adam, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 33
Neutrophils bearing adhesive polymer micropatches as a drug-free cancer immunotherapy
Ninad Kumbhojkar, Supriya Prakash, Tatsuya Fukuta, et al.
Nature Biomedical Engineering (2024) Vol. 8, Iss. 5, pp. 579-592
Closed Access | Times Cited: 28
Engineering and Targeting Neutrophils for Cancer Therapy
Jiahui Zhang, Jianmei Gu, Xu Wang, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Open Access | Times Cited: 25
The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting
Evgeniy Eruslanov, Yulia Nefedova, Dmitry I. Gabrilovich
Nature Immunology (2025) Vol. 26, Iss. 1, pp. 17-28
Closed Access | Times Cited: 2
Bidirectional role of neutrophils in tumor development
Haoxin Luyang, Feng Zeng, Lei Yan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Eliminating VEGFA+ tumor-associated neutrophils by antibody-drug conjugates boosts antitumor immunity and potentiates PD-1 immunotherapy in preclinical models of cervical cancer
Shili Yao, Lu Sun, Ye Lu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications
Siyao Liu, Wenchuan Wu, Yueshan Du, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 33
The Role of Cytokines in Neutrophil Development, Tissue Homing, Function and Plasticity in Health and Disease
Maria Tsioumpekou, Daniëlle Krijgsman, Jeanette H.W. Leusen, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1981-1981
Open Access | Times Cited: 32
Escape from T-cell–targeting immunotherapies in acute myeloid leukemia
Jayakumar Vadakekolathu, Sergio Rutella
Blood (2023) Vol. 143, Iss. 26, pp. 2689-2700
Open Access | Times Cited: 29
How Neutrophils Shape the Immune Response: Reassessing Their Multifaceted Role in Health and Disease
Areez Shafqat, Jibran Ahmad Khan, Aghiad Yahya Alkachem, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17583-17583
Open Access | Times Cited: 27
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Zhi Pang, Manman Lu, Yu Zhang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 26
CREB1-driven CXCR4hi neutrophils promote skin inflammation in mouse models and human patients
Jiaoling Chen, Yaxing Bai, Ke Xue, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease
Theodore S. Kapellos, Kevin Baßler, Wataru Fujii, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112525-112525
Open Access | Times Cited: 24
Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy
Ali Ghasemi, Amaia Martinez‐Usatorre, L. Li, et al.
Nature Cancer (2023) Vol. 5, Iss. 2, pp. 240-261
Open Access | Times Cited: 23
Beyond binary: bridging neutrophil diversity to new therapeutic approaches in NSCLC
Lena Horvath, Constanze Puschmann, Alexandra Scheiber, et al.
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 457-474
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top